前往化源商城

Oncogene 2015-03-12

KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway.

H Li, X Jiang, Y Yu, W Huang, H Xing, N Y Agar, H W Yang, B Yang, R S Carroll, M D Johnson

文献索引:Oncogene 34(11) , 1432-41, (2015)

全文:HTML全文

摘要

Aberrant splicing of the cyclin-dependent kinase-associated phosphatase, KAP, promotes glioblastoma invasion in a Cdc2-dependent manner. However, the mechanism by which this occurs is unknown. Here we show that miR-26a, which is often amplified in glioblastoma, promotes invasion in phosphatase and tensin homolog (PTEN)-competent and PTEN-deficient glioblastoma cells by directly downregulating KAP expression. Mechanistically, we find that KAP binds and activates ROCK2. Thus, RNA-mediated downregulation of KAP leads to decreased ROCK2 activity and this, in turn, increases Rac1-mediated invasion. In addition, the decrease in KAP expression activates the cyclin-dependent kinase, Cdk2, and this directly promotes invasion by increasing retinoblastoma phosphorylation, E2F-dependent Cdc2 expression and Cdc2-mediated inactivation of the actomyosin inhibitor, caldesmon. Importantly, glioblastoma cell invasion mediated by this pathway can be antagonized by Cdk2/Cdc2 inhibitors in vitro and in vivo. Thus, two distinct RNA-based mechanisms activate this novel KAP/ROCK2/Cdk2-dependent invasion pathway in glioblastoma.

相关化合物

结构式 名称/CAS号 全部文献
1,1'-双十八烷基-3,3,3',3'-四甲基吲哚菁高氯酸盐 结构式 1,1'-双十八烷基-3,3,3',3'-四甲基吲哚菁高氯酸盐
CAS:41085-99-8
Purvalanol A. 结构式 Purvalanol A.
CAS:212844-53-6